๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The purpose of this study is to determine whether MGL-3196 alters the pharm...
Status
Completed
Location
Celerion
Start Date
2016-04
Trial ID
NCT02749578
Treatments Being Tested
The purpose of this study is to directly characterize the pharmacokinetic (...
Status
Completed
Location
Madrigal Research Center
Start Date
2024-03-06
Trial ID
NCT06397872
Treatments Being Tested
The purpose of this study is determine in healthy males how MGL-3196 is met...
Status
Completed
Location
Worldwide Clinical Trials Early Phase Services, LLC
Start Date
2017-08-06
Trial ID
NCT03220165
Treatments Being Tested
A Phase 2 double-blind, randomized, placebo-controlled study to evaluate re...
Status
Recruiting
Location
University of California San Diego
Start Date
2025-12-29
Trial ID
NCT07335601
Treatments Being Tested
A double-blind placebo controlled randomized Phase 3 study to determine if ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-03-28
Trial ID
NCT03900429
Treatments Being Tested
This study will determine the effect of oral 80 mg resmetirom administered ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham (UAB)
Start Date
2022-08-26
Trial ID
NCT05500222
Treatments Being Tested
The purpose of this study is to determine whether the single and multiple-d...
Status
Completed
Location
Celerion
Start Date
2019-07-26
Trial ID
NCT04671069
Treatments Being Tested
A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Ev...
Status
Active Not Recruiting
Location
Central Research Associates
Start Date
2021-07-09
Trial ID
NCT04951219
Treatments Being Tested
A double-blind placebo controlled randomized Phase 3 study to evaluate the ...
Status
Completed
Location
Central Research Associates
Start Date
2019-12-16
Trial ID
NCT04197479
Treatments Being Tested
The purpose of this study is to determine whether MGL-3196 alters the pharm...
Status
Completed
Location
Celerion
Start Date
2015-09
Trial ID
NCT02542969
Treatments Being Tested